Cereno Scientific (NASDAQ First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that ...

Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that ...

Research suggests that it is important for clinicians to identify the risk for ILD in patients with SSc so that therapy can be initiated.

Only about 150 to 200 lung transplants are carried out in the UK each year and it can be hard to find a suitable donor ...

Humans can't live without lungs, but Ankit Bharat's patient did for 48 hours.

Different fibrotic interstitial lung diseases share demographic and functional similarities despite having different causes.

In fibrotic ILD, desaturation recovery post 6MWT is linked to disease progression, baseline disease severity, and transplant-free survival.

The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic pulmonary fibrosis into its Biomarker Qualification Program, according to a press ...

Meeting with the FDA to review the results from the Phase 3 EFZO-FIT™ study and determine the path forward for efzofitimod in pulmonary ...

In an interview with Targeted Oncology, Sarbajit Mukherjee, MD, GI medical oncologist at Baptist Health Miami Cancer ...

Laura Dern honors her mother's legacy. Diane Ladd died after fighting a progressive lung disease.

A novel recovery index (RI) integrates desaturation degree, recovery time, and supplemental oxygen use, offering prognostic ...